Новые возможности иммунотропной терапии врожденных инфекций у детей
А. М. Ожегов, Irina N. Petrova, Т. Ю. Тарасова et al. · Practical medicine · 2012
Under the supervision were 62 infants with intrauterine growth retardation: 32 patients with congenital infections (study group) and 30 children without infection (control group). In children the core group identified features of humoral immunity in the form of disimmunoglobulinemia and local immunity of the intestine, which showed low secretory IgA levels in serum and increased IgA and IgM in coprofiltrates. They noted increased production of IFN-γ, except for patients with CMV infection. The inclusion of the combined immunobiological drug in therapy improves the clinical course of the disease, has a modulating effect on cytokine status indicators and local intestinal secretory immune system, helps to reduce the rate of antibiotic therapy and reduce the length of hospitalization.
Cited by 0 works.